ACE and Alzheimer disease: We developed a new AD diagnostic kit, the QPLEXTM Alz plus assay kit, which predicts cerebral amyloid deposition using our previously developed blood biomarkers, LGALS3BP, Aβ1–40, ACE, and POSTN.